CCL2 and obesity disorder: As expected, patients with obesity (Groups II and III) showed significant elevations in plasma levels of triglycerides, nonesterified fatty acids, and inflammatory markers such as CCL2/MCP‐1, TNF‐α, plasma endotoxin (LPS), and LEP, along with a very significant increase in adipocyte size.